Radhakrishnan Maha 4
4 · Candel Therapeutics, Inc. · Filed Jun 6, 2025
Insider Transaction Report
Form 4
Radhakrishnan Maha
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-06-04+28,480→ 28,480 totalExercise: $5.60Exp: 2035-06-04→ Common Stock (28,480 underlying)
Footnotes (1)
- [F1]The shares underlying this option shall vest and become exercisable in 36 equal monthly installments, subject to the Reporting Person's continued service on each such vesting date.